CA3024286A1 - Use of carbamate compound for preventing or treating fibromyalgia or functional syndrome associated with fibromyalgia - Google Patents
Use of carbamate compound for preventing or treating fibromyalgia or functional syndrome associated with fibromyalgia Download PDFInfo
- Publication number
- CA3024286A1 CA3024286A1 CA3024286A CA3024286A CA3024286A1 CA 3024286 A1 CA3024286 A1 CA 3024286A1 CA 3024286 A CA3024286 A CA 3024286A CA 3024286 A CA3024286 A CA 3024286A CA 3024286 A1 CA3024286 A1 CA 3024286A1
- Authority
- CA
- Canada
- Prior art keywords
- fibromyalgia
- group
- alkyl
- formula
- carbamate compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20160061392 | 2016-05-19 | ||
| KR10-2016-0061392 | 2016-05-19 | ||
| PCT/KR2017/005173 WO2017200318A1 (ko) | 2016-05-19 | 2017-05-18 | 섬유근육통 또는 섬유근육통의 연관된 기능적 증후군을 예방 또는 치료하기 위한 카바메이트 화합물의 용도 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3024286A1 true CA3024286A1 (en) | 2017-11-23 |
Family
ID=60325216
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3024286A Pending CA3024286A1 (en) | 2016-05-19 | 2017-05-18 | Use of carbamate compound for preventing or treating fibromyalgia or functional syndrome associated with fibromyalgia |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10849882B2 (https=) |
| EP (1) | EP3459543B1 (https=) |
| JP (1) | JP7071287B2 (https=) |
| KR (1) | KR102489052B1 (https=) |
| CN (1) | CN109475529B (https=) |
| AU (1) | AU2017265839B2 (https=) |
| BR (1) | BR112018073553A2 (https=) |
| CA (1) | CA3024286A1 (https=) |
| DK (1) | DK3459543T3 (https=) |
| ES (1) | ES2935596T3 (https=) |
| MX (1) | MX394245B (https=) |
| PL (1) | PL3459543T3 (https=) |
| RU (1) | RU2753525C2 (https=) |
| WO (1) | WO2017200318A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11033531B2 (en) * | 2016-12-14 | 2021-06-15 | Sk Biopharmaceuticals Co., Ltd. | Use of carbamate compound for preventing, alleviating, or treating tremors or tremor syndrome |
| PT3711758T (pt) | 2017-11-14 | 2024-04-22 | Sk Biopharmaceuticals Co Ltd | Utilização de composto de carbamato para prevenir, aliviar ou tratar crise de ausência ou epilepsia que apresenta crise de ausência |
| WO2019098633A1 (ko) * | 2017-11-14 | 2019-05-23 | 에스케이바이오팜 주식회사 | 내장통 또는 내장 질환에서 기인한 통증을 예방, 경감 또는 치료하기 위한 카바메이트 화합물의 용도 |
| EP3711760B1 (en) * | 2017-11-14 | 2024-02-14 | SK Biopharmaceuticals Co., Ltd. | Use of carbamate compound for preventing or treating diseases associated with increase in late sodium current |
| AU2019361856B2 (en) * | 2018-10-19 | 2024-11-07 | Sk Biopharmaceuticals Co., Ltd. | Use of carbamate compound for preventing, alleviating or treating diabetic peripheral neuropathy or chemotherapy-induced peripheral neuropathy |
| BR112022009533A2 (pt) * | 2019-11-22 | 2022-08-02 | Sk Biopharmaceuticals Co Ltd | Composição farmacêutica para administração oral, e, método para preparar uma composição farmacêutica |
| IT202300007314A1 (it) | 2023-04-14 | 2024-10-14 | Soal Pharma Srl | Integratore alimentare per il trattamento della fibromialgia |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3415840A (en) | 1965-10-22 | 1968-12-10 | American Home Prod | Pyrazole-1-ethanol derivatives |
| DK1406606T3 (da) * | 2001-07-16 | 2007-03-05 | Ortho Mcneil Pharm Inc | Carbamatforbindelser til forebyggelse eller behandling af neuropatisk smerte og smerte forbundet med klynge- og migrænehovedpine |
| US7598279B2 (en) * | 2005-04-22 | 2009-10-06 | Sk Holdings Co., Ltd. | Neurotherapeutic azole compounds |
| WO2010150946A1 (en) | 2009-06-22 | 2010-12-29 | Sk Holdings Co., Ltd. | Method for preparation of carbamic acid (r)-1-aryl-2-tetrazolyl-ethyl ester |
| US8404461B2 (en) | 2009-10-15 | 2013-03-26 | SK Biopharmaceutical Co. Ltd. | Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester |
| EP2496227B1 (en) * | 2009-11-06 | 2019-05-22 | SK Biopharmaceuticals Co., Ltd. | Methods for treating fibromyalgia syndrome |
-
2017
- 2017-05-16 KR KR1020170060714A patent/KR102489052B1/ko active Active
- 2017-05-18 US US16/302,858 patent/US10849882B2/en active Active
- 2017-05-18 WO PCT/KR2017/005173 patent/WO2017200318A1/ko not_active Ceased
- 2017-05-18 CN CN201780030906.XA patent/CN109475529B/zh active Active
- 2017-05-18 JP JP2018560460A patent/JP7071287B2/ja active Active
- 2017-05-18 EP EP17799675.8A patent/EP3459543B1/en active Active
- 2017-05-18 ES ES17799675T patent/ES2935596T3/es active Active
- 2017-05-18 AU AU2017265839A patent/AU2017265839B2/en active Active
- 2017-05-18 CA CA3024286A patent/CA3024286A1/en active Pending
- 2017-05-18 PL PL17799675.8T patent/PL3459543T3/pl unknown
- 2017-05-18 MX MX2018014080A patent/MX394245B/es unknown
- 2017-05-18 DK DK17799675.8T patent/DK3459543T3/da active
- 2017-05-18 RU RU2018144785A patent/RU2753525C2/ru active
- 2017-05-18 BR BR112018073553-1A patent/BR112018073553A2/pt not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2017265839A1 (en) | 2018-12-13 |
| RU2018144785A3 (https=) | 2020-08-11 |
| DK3459543T3 (da) | 2023-02-13 |
| CN109475529B (zh) | 2022-02-22 |
| RU2018144785A (ru) | 2020-06-19 |
| JP2019516707A (ja) | 2019-06-20 |
| KR102489052B1 (ko) | 2023-01-16 |
| US10849882B2 (en) | 2020-12-01 |
| JP7071287B2 (ja) | 2022-05-18 |
| CN109475529A (zh) | 2019-03-15 |
| ES2935596T3 (es) | 2023-03-08 |
| RU2753525C2 (ru) | 2021-08-17 |
| AU2017265839B2 (en) | 2022-10-27 |
| US20190298694A1 (en) | 2019-10-03 |
| MX2018014080A (es) | 2019-04-04 |
| EP3459543A1 (en) | 2019-03-27 |
| MX394245B (es) | 2025-03-19 |
| BR112018073553A2 (pt) | 2019-03-19 |
| KR20170131242A (ko) | 2017-11-29 |
| EP3459543A4 (en) | 2020-01-15 |
| PL3459543T3 (pl) | 2023-04-11 |
| EP3459543B1 (en) | 2022-12-21 |
| WO2017200318A1 (ko) | 2017-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10849882B2 (en) | Use of carbamate compound for preventing or treating fibromyalgia or functional syndrome associated with fibromyalgia | |
| US20240366566A1 (en) | Use of carbamate compound for prevention, alleviation or treatment of status epilepticus | |
| IL274431B1 (en) | Use of a carbamate compound to reduce or treat developmental disorders including fragile X syndrome, Engelmann syndrome, or Rett syndrome | |
| US11207295B2 (en) | Use of carbamate compound for preventing or treating trigeminal neuralgia | |
| US11571410B2 (en) | Use of carbamate compounds for prevention, alleviation or treatment of bipolar disorder | |
| IL274428B2 (en) | Use of a carbamate compound to prevent, relieve or treat a withdrawal seizure or epilepsy presenting with a withdrawal seizure | |
| EP3854391B1 (en) | Carbamate compound and use of formulation comprising same in preventing, alleviating, or treating acute stress disorder or post-traumatic stress disorder | |
| US12611395B2 (en) | Use of carbamate compound for preventing or treating trigeminal neuralgia | |
| HK40005640B (en) | Use of carbamate compound for preventing or treating fibromyalgia or functional syndrome associated with fibromyalgia | |
| HK40005640A (en) | Use of carbamate compound for preventing or treating fibromyalgia or functional syndrome associated with fibromyalgia | |
| CA3116195A1 (en) | Use of carbamate compound for preventing, alleviating or treating diabetic peripheral neuropathy or chemotherapy-induced peripheral neuropathy | |
| BR112018073556B1 (pt) | Uso de um composto de carbamato |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20220425 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 8TH ANNIV.) - STANDARD Year of fee payment: 8 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250219 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20250219 Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250219 |
|
| D22 | Grant of ip right intended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D22-D128 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALLOWANCE REQUIREMENTS DETERMINED COMPLIANT Effective date: 20250819 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20250819 |